Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; National Institute for Health Research Biomedical Research Centre South London and Maudsley National Health Service Trust, King's College London, London, United Kingdom.
Biol Psychiatry. 2020 Mar 1;87(5):419-430. doi: 10.1016/j.biopsych.2019.06.031. Epub 2019 Aug 5.
The prevalence of depression is higher in individuals with autoimmune diseases, but the mechanisms underlying the observed comorbidities are unknown. Shared genetic etiology is a plausible explanation for the overlap, and in this study we tested whether genetic variation in the major histocompatibility complex (MHC), which is associated with risk for autoimmune diseases, is also associated with risk for depression.
We fine-mapped the classical MHC (chr6: 29.6-33.1 Mb), imputing 216 human leukocyte antigen (HLA) alleles and 4 complement component 4 (C4) haplotypes in studies from the Psychiatric Genomics Consortium Major Depressive Disorder Working Group and the UK Biobank. The total sample size was 45,149 depression cases and 86,698 controls. We tested for association between depression status and imputed MHC variants, applying both a region-wide significance threshold (3.9 × 10) and a candidate threshold (1.6 × 10).
No HLA alleles or C4 haplotypes were associated with depression at the region-wide threshold. HLA-B*08:01 was associated with modest protection for depression at the candidate threshold for testing in HLA genes in the meta-analysis (odds ratio = 0.98, 95% confidence interval = 0.97-0.99).
We found no evidence that an increased risk for depression was conferred by HLA alleles, which play a major role in the genetic susceptibility to autoimmune diseases, or C4 haplotypes, which are strongly associated with schizophrenia. These results suggest that any HLA or C4 variants associated with depression either are rare or have very modest effect sizes.
自身免疫性疾病患者中抑郁症的患病率较高,但观察到的合并症的发病机制尚不清楚。共同的遗传病因学是重叠的一个合理解释,在这项研究中,我们测试了主要组织相容性复合体(MHC)中的遗传变异是否也与抑郁症的风险相关,MHC 与自身免疫性疾病的风险相关。
我们精细映射了经典 MHC(chr6:29.6-33.1 Mb),在精神疾病基因组学联盟重度抑郁症工作组和英国生物库的研究中,对 216 个人类白细胞抗原(HLA)等位基因和 4 个补体成分 4(C4)单倍型进行了推断。总样本量为 45149 例抑郁症病例和 86698 例对照。我们测试了抑郁症状态与推断的 MHC 变体之间的关联,应用了全区域显著性阈值(3.9×10)和候选者阈值(1.6×10)。
在全区域阈值下,没有 HLA 等位基因或 C4 单倍型与抑郁症相关。在 HLA 基因的候选者检验的荟萃分析中,HLA-B*08:01 与抑郁症的适度保护相关(比值比=0.98,95%置信区间=0.97-0.99)。
我们没有发现 HLA 等位基因或 C4 单倍型会增加患抑郁症的风险的证据,HLA 等位基因在自身免疫性疾病的遗传易感性中起主要作用,而 C4 单倍型与精神分裂症密切相关。这些结果表明,与抑郁症相关的任何 HLA 或 C4 变体要么非常罕见,要么效应大小非常小。